|
TESK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70707892266364E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.54778445405191E-13 |
| Normal-vs-Stage2 |
1.166930E-04 |
| Normal-vs-Stage3 |
7.43849426498855E-15 |
| Normal-vs-Stage4 |
6.8914000062037E-09 |
| Stage1-vs-Stage2 |
4.071400E-01 |
| Stage1-vs-Stage3 |
4.463600E-02 |
| Stage1-vs-Stage4 |
1.993950E-01 |
| Stage2-vs-Stage3 |
2.174200E-02 |
| Stage2-vs-Stage4 |
8.846200E-02 |
| Stage3-vs-Stage4 |
9.669200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62814206561279E-12 |
| Normal-vs-AfricanAmerican |
5.81370000000136E-05 |
| Normal-vs-Asian |
5.276400E-03 |
| Caucasian-vs-AfricanAmerican |
6.529600E-02 |
| Caucasian-vs-Asian |
1.590640E-01 |
| AfricanAmerican-vs-Asian |
8.724800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63036251166204E-12 |
| Normal-vs-Female |
3.80739999999991E-05 |
| Male-vs-Female |
2.430500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.71394999999297E-05 |
| Normal-vs-Extreme_Weight |
1.62492241884138E-12 |
| Normal-vs-Obese |
6.23869844673663E-11 |
| Normal-vs-Extreme_Obese |
1.07913677993565E-13 |
| Normal_Weight-vs-Extreme_Weight |
5.438600E-01 |
| Normal_Weight-vs-Obese |
9.589800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.023210E-01 |
| Extreme_Weight-vs-Obese |
2.690000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.529600E-02 |
| Obese-vs-Extreme_Obese |
7.484600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.85459999977067E-07 |
| Normal-vs-Age(41-60Yrs) |
1.89193105626373E-12 |
| Normal-vs-Age(61-80Yrs) |
1.82631687550838E-13 |
| Normal-vs-Age(81-100Yrs) |
7.74650343871031E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.610200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.095000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.488400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.072600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.601800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.108000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
5.67650004779097E-09 |
| Normal-VS-KIRP CIMP |
1.98754999999329E-05 |
| Normal-VS-Unclassified PRCC |
2.20269999995359E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.329800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.828800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.577000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.280200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.790200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.077000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
2.6949553699751E-12 |
| Normal-vs-N2 |
1.184530E-03 |
| N0-vs-N1 |
6.999600E-01 |
| N0-vs-N2 |
4.727800E-01 |
| N1-vs-N2 |
3.957200E-01 |
|
|
